Financials
- Market Capitalization 2.19 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-6.2
市销率
0.99
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1923 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.60 USD | -1.58% | -0.31% | -0.78% | -36.59% | 2.26 B USD | ||
| 1924 | MESO Mesoblast Limited - American Depositary Shares | 16.75 USD | -3.96% | +0.48% | +18.63% | +28.35% | 2.17 B USD | ||
| 1948 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -1.69% | +10.67% | +36.55% | 2.17 B USD | ||
| 1961 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +15.67% | +129.58% | 2.13 B USD |